Perrigo (PRGO) Current Taxes (2013 - 2026)
Perrigo's (PRGO) quarterly Current Taxes came in at $28.6 million in Q1 2026, up 98.61% year-on-year from $14.4 million in Q1 2025, and up 37.5% on a QoQ basis from $20.8 million in Q4 2025.
Perrigo (PRGO) Current Taxes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Current Taxes data on file, last reported at $28.6 million in Q1 2026.
- On a quarterly basis, Current Taxes rose 98.61% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $28.6 million, a 98.61% increase from a year earlier, with the FY2025 full-year figure at $20.8 million, up 19.54% from the prior year.
- Current Taxes for Q1 2026 stood at $28.6 million, up from $20.8 million in the prior quarter.
- Over the last five years, Current Taxes for PRGO reached as high as $42.1 million in Q4 2023 and fell as low as $5.0 million in Q3 2022.
- Historically, Current Taxes has averaged $14.8 million across 5 years, with a median of $11.8 million in 2024.
- Across the five-year window, Current Taxes tumbled 93.74% in 2022 and surged 225.93% in 2023, its largest moves.
- Year by year, Current Taxes stood at $14.4 million in 2022, then surged by 192.36% to $42.1 million in 2023, then plunged by 58.67% to $17.4 million in 2024, then increased by 19.54% to $20.8 million in 2025, then soared by 37.5% to $28.6 million in 2026.
- Per Business Quant data, the three most recent Current Taxes figures were $28.6 million in Q1 2026, $20.8 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 28.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 28.60 Mn |
| Dec 31, 2025 | 20.80 Mn |
| Sep 27, 2025 | 5.90 Mn |
| Jun 28, 2025 | 10.30 Mn |
| Mar 29, 2025 | 14.40 Mn |
| Dec 31, 2024 | 17.40 Mn |
| Sep 28, 2024 | 10.00 Mn |
| Jun 29, 2024 | 11.80 Mn |
| Mar 30, 2024 | 7.70 Mn |
| Dec 31, 2023 | 42.10 Mn |
| Sep 30, 2023 | 9.80 Mn |
| Jul 1, 2023 | 7.60 Mn |
| Apr 1, 2023 | 17.60 Mn |
| Dec 31, 2022 | 14.40 Mn |
| Oct 1, 2022 | 22.10 Mn |
| Jul 2, 2022 | 5.00 Mn |
| Apr 2, 2022 | 5.40 Mn |
| Dec 31, 2021 | 16.50 Mn |
| Oct 2, 2021 | 353.00 Mn |
| Jul 3, 2021 | 9.40 Mn |